Trump Admin
This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in public health, say supporters.
ACMG, NSGC, and others in the genetics community are monitoring whether the widely used online clinical genetics database could be at risk.
Federal Court Permanently Enjoins NIH From Cutting Indirect Costs to Research Grants
The US District Court for the District of Massachusetts called the Trump administration policy "arbitrary and capricious."
NIH Funding Cuts Threaten Research, Clinical Trials, Precision Oncology Progress, Leaders Say
Premium
Researchers warn NIH divestment from research could hinder progress at a pivotal moment for advances in precision cancer medicine.
Precision Medicine Supporters Worry About NIH Indirect Rate Cut's Impact on Advances, Workforce
Premium
Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.